These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21921339)

  • 1. Preneoplastic and neoplastic megakaryocyte/platelet disorders: three case reports.
    Kumar A; Kushwaha R; Singh US
    Indian J Cancer; 2011; 48(3):363-4. PubMed ID: 21921339
    [No Abstract]   [Full Text] [Related]  

  • 2. [Morphological analysis of the megakaryocytes in myelodysplastic syndrome].
    Mori H; Niikura H; Terada H; Fujita K
    Rinsho Byori; 1990 Dec; 38(12):1347-52. PubMed ID: 2082033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered immunophenotypic features of peripheral blood platelets in myelodysplastic syndromes.
    Sandes AF; Yamamoto M; Matarraz S; Chauffaille Mde L; Quijano S; López A; Oguro T; Kimura EY; Orfao A
    Haematologica; 2012 Jun; 97(6):895-902. PubMed ID: 22271903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic significance of the number of bone marrow megakaryocytes in cases with decreased platelet production evidenced by platelet kinetic study].
    Tsukada T; Ueyama J; Miyakoshi S; Morinaga S; Mutoh Y; Yamaguchi H; Matsuya S
    Rinsho Ketsueki; 1990 Jul; 31(7):903-10. PubMed ID: 2214187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bleeding time is inversely related to megakaryocyte nuclear DNA content and size in man.
    Dalby Kristensen S; Bath PM; Martin JF
    Thromb Haemost; 1988 Jun; 59(3):357-9. PubMed ID: 3187928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in the megakaryocyte-platelet system in chronic neutrophilic leukemia].
    Mori H; Ikegami T; Shimizu T; Harada H; Miyoshi Y; Okada S; Takizawa Y; Niikura H; Terada H; Fujita K
    Rinsho Ketsueki; 1991 Dec; 32(12):1574-6. PubMed ID: 1779459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excessive naked megakaryocyte nuclei in myelodysplastic syndrome mimicking idiopathic thrombocytopenic purpura: a complicated pre- and post-transplantation course.
    Olcay L; Tuncer AM; Okur H; Erdemli E; Uysal Z; Cetin M; Duru F; Cetinkaya DU
    Pediatr Hematol Oncol; 2009 Sep; 26(6):387-97. PubMed ID: 19657988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow biopsy of aplastic anemia, myelodysplastic syndromes and myeloproliferative disorders.
    Kikuchi M
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1339-46. PubMed ID: 3247814
    [No Abstract]   [Full Text] [Related]  

  • 9. Apoptotic megakaryocyte dysplasia in the myelodysplastic syndromes.
    Hatfill SJ; Fester ED; Steytler JG
    Hematol Pathol; 1992; 6(2):87-93. PubMed ID: 1607344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dysmegakaryocytopoiesis and dysthrombopoiesis in myeloproliferative syndromes].
    Brière J; Kiladjian JJ; Peynaud-Debayle E
    C R Seances Soc Biol Fil; 1996; 190(5-6):533-9. PubMed ID: 9074718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megakaryocytes in the giant platelet syndrome. A cytochemical and ultrastructural study.
    Kass L; Leichtman DA; Beals TF; Schnitzer B
    Thromb Haemost; 1977 Oct; 38(3):652-9. PubMed ID: 579510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered megakaryocyte-platelet haemostatic axis in hypercholesterolaemia.
    Pathansali R; Smith N; Bath P
    Platelets; 2001 Aug; 12(5):292-7. PubMed ID: 11487381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on pathophysiology of the myelodysplastic syndromes (MDS)--pattern of dysmegakaryopoiesis related to leukemic transformation].
    Tomonaga M; Jinnai I; Kuriyama K; Nonaka H; Amenomori T; Matsuo T; Yoshida Y; Sasagawa I; Sadamori N; Ichimaru M
    Rinsho Ketsueki; 1989 Oct; 30(10):1788-99. PubMed ID: 2593245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on megakaryocytes and platelets in three cases of primary thrombocythemia (author's transl)].
    Tanoue K; Onozawa Y; Adachi Y; Kashiwagi H; Okubo Y
    Rinsho Ketsueki; 1974 May; 15(5):447-86. PubMed ID: 4471912
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet mass has prognostic value in patients with myelodysplastic syndromes.
    Bowles KM; Warner BA; Baglin TP
    Br J Haematol; 2006 Oct; 135(2):198-200. PubMed ID: 16939490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic changes in the megakaryocyte-platelet lineage.
    Stenberg PE
    Scanning Microsc; 1988 Dec; 2(4):2117-27. PubMed ID: 3238385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes.
    Tang G; Wang SA; Menon M; Dresser K; Woda BA; Hao S
    Leuk Res; 2011 Jun; 35(6):766-70. PubMed ID: 21367453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balloon-like platelets in myelodysplastic syndromes--a feature of dysmegakaryopoiesis?
    Widell S; Hast R
    Leuk Res; 1987; 11(8):747-52. PubMed ID: 3306168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of immature platelet fraction for the clinical evaluation of myelodysplastic syndromes.
    Saigo K; Takenokuchi M; Imai J; Numata K; Isono S; Zenibayashi M; Tanioka H; Yoshioka T; Nishizawa A; Takada M; Nomura T; Kubota Y
    Lab Hematol; 2009; 15(2):13-6. PubMed ID: 19561008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet phagocytosis by granulopoietic precursors in a myelodysplastic syndrome overexpressing the P-selectin gene.
    Morales-Camacho RM; Serrano-Chacón MD; Prats-Martín C; Vargas MT; Bernal R; Burillo-Sanz S
    Br J Haematol; 2017 Apr; 177(2):171. PubMed ID: 28211570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.